Results 51 to 60 of about 2,265,448 (242)

A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)

open access: yesMilitary Medical Research, 2020
In December 2019, a new type viral pneumonia cases occurred in Wuhan, Hubei Province; and then named “2019 novel coronavirus (2019-nCoV)” by the World Health Organization (WHO) on 12 January 2020.
Ying-Hui Jin   +46 more
doaj   +1 more source

2019 novel coronavirus of pneumonia in Wuhan, China: emerging attack and management strategies

open access: yesClinical and Translational Medicine, 2020
An ongoing outbreak of 2019-nCoV pneumonia was first identified in Wuhan, Hubei province, China at the end of 2019. With the spread of the new coronavirus accelerating, person-to-person transmission in family homes or hospitals, and intercity spread of ...
Jun She   +5 more
doaj   +1 more source

Medical Journals and the 2019-nCoV Outbreak

open access: yesNew England Journal of Medicine, 2020
Medical Journals and the Coronavirus The editors announce expedited handling for submitted manuscripts describing the 2019-nCoV outbreak and make broad recommendations for speed, transparency, and ...
Rubin, Eric J.   +3 more
openaire   +2 more sources

Molecular Insights into the Contagious Nature of Pandemic Novel Coronavirus 2019-nCoV

open access: yes, 2020
This article stems from the author's observations that ORF10, a protein with no sequence and structural conservation, provides with a high number of potentially immunogenic, promiscuous epitopes.
Seema Mishra (8621172)
core   +1 more source

Nueva Vitrina del Conocimiento sobre el 2019-nCov [PDF]

open access: yes, 2020
El Centro especializado de la Organización Panamericana de la Salud/Organización Mundial de la Salud (BIREME), en el marco de su misión de democratizar información, conocimiento y evidencia para la toma de decisiones en salud, ha desarrollado una Vitrina
Jimenez-Planet, Virginia   +1 more
core  

Learning from the Past: Possible Urgent Prevention and Treatment Options for Severe Acute Respiratory Infections Caused by 2019-nCoV

open access: yes, 2020
With the current trajectory of the 2019-nCoV outbreak unknown, public health and medicinal measures will both be needed to contain spreading of the virus and to optimize patient outcomes.
Jared S. Morse (8279574)   +3 more
core   +1 more source

In silico identification of vaccine targets for 2019-nCoV [version 1; peer review: 2 approved]

open access: yesF1000Research, 2020
Background: The newly identified coronavirus known as 2019-nCoV has posed a serious global health threat. According to the latest report (18-February-2020), it has infected more than 72,000 people globally and led to deaths of more than 1,016 people in ...
Chloe Hyun-Jung Lee, Hashem Koohy
doaj   +1 more source

2019-nCoV – Towards a 4th generation vaccine [PDF]

open access: yesBioinformation, 2020
The first report of the unusual manifestation of pneumonia-like symptoms in Wuhan City, China was made on 31 December 2019. Within one week, the Chinese authorities reported that they had identified the causative agent as a new member of the Coronavirus family, the same family of that was responsible for MERS and SARS not so many years ago.
openaire   +2 more sources

Mutations, Recombination and Insertion in the Evolution of 2019-nCoV [PDF]

open access: yes, 2020
Abstract Background The 2019 novel coronavirus (2019-nCoV or SARS-CoV-2) has spread more rapidly than any other betacoronavirus including SARS-CoV and MERS-CoV. However, the mechanisms responsible for infection and molecular evolution of this virus remained unclear.
Wu, Aiping   +25 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy